Conjugated Estrogens

Weekly News Recap
#Phispers

Stock Recap
#PipelineProspector

Virtual Booth

Contact Supplier

Access all COS suppliers
Check all USDMF suppliers

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

21 API Suppliers, 14 USDMF, 1 CEP/COS, 3 EU WC, 1 KDMF, 7 NDC API, 3 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

FINISHED DOSAGE FORMULATIONS

119 FDF Dossiers, 38 FDA Orange Book, 55 Europe, 10 Canada, 14 South Africa, 2 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 20MG BASE;0.45MG, TABLET;ORAL - 0.3MG, TABLET;ORAL - 0.45MG, TABLET;ORAL - 0.625MG, TABLET;ORAL - 0.9MG, TABLET;ORAL - 1.25MG

RELATED EXCIPIENT COMPANIES

4 SPI Pharma, 4 DKSH, 3 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 1 Kirsch Pharma, 1 ACG Worldwide, 5 Actylis, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 11 BASF, 11 Corel Pharma Chem, 4 DFE Pharma, 1 Esteem Industries, 1 Finar, 8 Gangwal Chemicals, 4 Ideal Cures, 2 Ingredion Pharma Solutions, 20 Kerry, 1 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 10 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 15 Roquette, 13 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 8 Sigachi Industries, 2 Silverline Chemicals, 3 The Dow Chemical Company, 2 Vasa Pharmachem, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

43 Fillers, Diluents & Binders, 41 Coating Systems & Additives, 21 Controlled & Modified Release, 20 Direct Compression, 19 Granulation, 18 Thickeners and Stabilizers, 15 Solubilizers, 12 Film Formers & Plasticizers, 11 Topical, 11 Co-Processed Excipients, 10 Taste Masking, 9 Lubricants & Glidants, 8 Chewable & Orodispersible Aids, 8 Disintegrants & Superdisintegrants, 7 Parenteral, 5 Emulsifying Agents, 5 Rheology Modifiers, 5 Empty Capsules, 4 Surfactant & Foaming Agents, 4 API Stability Enhancers, 4 Coloring Agents, 4 Vegetarian Capsules

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 11 News #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 50 Regulatory FDF Prices, 11 Annual Reports

MARKET PLACE

12 APIs, 1 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 US Patents

2 US Patents

REF. STANDARDS & IMPURITIES

3 EDQM

3 EDQM

Xls

Filters

Company Name

Year

DEALS // DEV.

Country

Sponsor

Therapeutic Area

Study Phase

Deal Type

Product Type

Dosage Form

Lead Product

Target

Filters

Reset Filter

All Developments

Therapeutic Area by Lead Product

Study Phase by Lead Product

Company by Lead Product

Top Deals by Deal Size (USD bn)

Reset All

01

Aspen Pharmacare Holdings

South Africa

ISPE Annual Meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Lead Product(s) : Conjugated Estrogens

Therapeutic Area : Obstetrics/Gynecology (Women’s Health)

Study Phase : Approved FDF

Sponsor : Avion Pharmaceuticals

Deal Size : Undisclosed

Deal Type : Partnership

DEALS_DEV

Aspen Concludes Strategic Partnership with U.S-Based Avion Pharmaceuticals

Details : Avion Pharmaceuticals gets exclusive rights to relaunch Cenestin® in the USA. Cenestin® is the only plant-derived mixture of nine conjugated estrogens indicated for treatment of moderate to severe symptoms of vasomotor, and vulvar and vaginal atrophy d...

Product Name : Cenestin

Product Type : Miscellaneous

Upfront Cash : Undisclosed

November 12, 2020